Financing the fight against TB The Global Funds Contribution

1
Financing the fight against TB The Global Funds
Contribution

• Helen Evans
• Deputy Executive Director
• The Global Fund

2

• Thanks to the work of the Stop TB
• Partnership in supporting the
• countries
• The success rate of proposals to the Fund remains
  high
• TB grants are also performing well

3
With Brazil and Albania successful in Round 5,
Global Fund is now the largest donor for TB
globally (Blue)
Albania Georgia Kyrgyzstan Moldova
(HIV/TB) Romania Russian Federation Serbia Tajikis
tan Yemen
82 countries 105 TB Grants US 612 Million (2
years) US 1.7 Billion (5 years)
Afghanistan Bangladesh Bhutan Cambodia China East
Timor India Indonesia Laos Mongolia Myanmar Nepal
Pakistan Philippines Sri Lanka Thailand Vietnam We
stern Pacific Islands
Angola Benin Burkina Faso Burundi Cameroon Central
African Republic Chad Congo (Dem Rep) Côte
dIvoire Egypt Ethiopia Ghana Guinea-Bissau Kenya
Lesotho
Liberia Madagascar Mali Mauritania Mozambique Nami
bia Rwanda Sierra Leone Somalia South Africa
(HIV/TB) Sudan Swaziland Tanzania Togo Uganda Zamb
ia
Brazil Bolivia Dominican Republic Ecuador El
Salvador Guyana Haiti Honduras (Integrated) Nicara
gua Panama Paraguay Peru
4
TB Grants have steadily increased their share of
resources, particularly in Round 5
US571 M US855 M US615
M US1018 M US726 M
US3.785 M
11
17
13
15
17
27
12
28
29
29
40
27
71
61
58
53
45
40
2 Year Budgets
5
TB Grants are expected to reach over 5yrs for
Rounds 1-5

• 5 million additional TB cases to be detected
  under DOTS
• 24,600 new DOTS treatments for drug-resistant TB
  distributed
• In addition
• -1.8 million people to be on ARV treatment some
  being TB cases
• -62 million clients to receive HIV counseling and
  testing including TB cases

6
Projected DOTS coverage per Round of approved
proposals over 5 years
Thousands of smear positive cases detected under
DOTS (over proposal lifetime)
5.000M
1.533M
0.636M
757
734
1.340
DOTS cases detected with Round 1
Total cases detected by all approved programs
DOTS cases detected with Round 2
DOTS cases detected with Round 3
DOTS cases detected with Round 4
DOTS cases detected with Round 5
7
Projected treatments for Multidrug-resistant TB
(MDR-TB) with DOTS
Cumulative number of MDR-TB treatments provided
(over proposal lifetime)
12,500
24,600
8,100
4,000
Initial treatments with GLC
Treatments provided with Round 1-4 funds
Total treatments provided through Global Fund
with GLC mechanism
Treatments provided with Round 5 funds
DOTS is the approved treatment strategy for
MDR-TB. Rounds 1-4 figures are based on drug
purchase approval by the Green Light Committee
(GLC), which approves DOTS pilot programs,
consistent with Board policy on procurement of
MDR-TB medicines. Round 3 figures subject to
change based on GLC applications and approvals.
8
TB grants perform well Most grants achieved
Grade A or B1 in
(a) Fragile states
(b) Stable states
9

• The Global Fund commits to fully
• support implementation of the new
• Global Plan to Stop TB
• I thank you